NITROLINGUAL

This brand name is authorized in Austria, Australia, Germany, Estonia, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug NITROLINGUAL contains one active pharmaceutical ingredient (API):

1 Glyceryl trinitrate UNII G59M7S0WS3 - NITROGLYCERIN

Glyceryl trinitrate is a vasodilator and is used for angina of effort. Vasodilation is achieved by the releasing of free redical nitric oxide which activates guanylate cyclase and increases synthesis of guanosine 3′ and 5′-monophosphate with resultant effects on the phosphorylation of proteins in smooth muscle. If taken in excess, its vasodilatory effect can cause headache. Read about Glyceryl trinitrate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NITROLINGUAL Sublingual spray	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01DA02	Glyceryl trinitrate	C Cardiovascular system → C01 Cardiac therapy → C01D Vasodilators used in cardiac diseases → C01DA Organic nitrates
Discover more medicines within C01DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 3475X, 8171C
Country: CA	Health Products and Food Branch	Identifier(s): 02231441
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 11084508, 15318854, 16357856, 16794479
Country: EE	Ravimiamet	Identifier(s): 1152290, 1298606
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 183521, 183523, 183529, 183531, 220291, 240026, 381561
Country: HK	Department of Health Drug Office	Identifier(s): 35453
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-453122375
Country: IE	Health Products Regulatory Authority	Identifier(s): 40664, 42433
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3413
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1001386
Country: MT	Medicines Authority	Identifier(s): AA521/07003, AA565/42601, AA770/13701, AA908/09202
Country: NL	Z-Index G-Standaard	Identifier(s): 14947641
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 72214
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 3542
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699738520014
Country: US	FDA, National Drug Code	Identifier(s): 28595-550
Country: ZA	Health Products Regulatory Authority	Identifier(s): P/7.1.4/281